GLP-1 therapies are rapidly reshaping the landscape of metabolic care—offering new hope for individuals with diabetes, obesity, and related conditions, while raising important questions for employers around affordability, access, and long-term value. This webinar will help to equip employer decision-makers with practical, actionable insights into one of the most transformative drug classes of our time, with a clear focus on balancing innovation with sustainability.

An employer panel will share real-world perspectives on the challenges and opportunities associated with GLP-1 coverage, benefit design, and the growing array of point solutions being deployed across the market.

Key topics include:

• Benefit design considerations: Navigating coverage strategies, utilization management, and long-term value in a rapidly evolving therapeutic class
• Employer action steps: Assessing organizational impact, building the business case for leadership, designing an effective benefit strategy, and measuring success
• Future outlook: The role of GLP-1s within broader metabolic health strategies and what emerging pipeline innovations may mean for employers

Register here.